By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

A man who was diagnosed with the deadliest form of brain cancer has shown no signs of the disease after being treated with ...

Replimune faces FDA hurdles for RP1, an innovative melanoma treatment, as it seeks a path forward after receiving a complete ...

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

The 81,000-square-foot facility will enhance the health system's cancer care offerings in the UK, with completion expected in ...

SCOPE is testing administration of intramuscular SCIB1 and intradermal iSCIB1+, which codes for various melanoma antigens ...

Interleukin-18 (IL-18) is a pro-inflammatory cytokine that plays a crucial role in promoting antitumor immunity by activating T and natural killer (NK) cells. However, the therapeutic use of wild-type ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

Our research, if it is successful, then we will develop a new immunotherapy, so the next step will be a clinical trial,” said MSU professor Dohun Pyeon.